-
Merck: Strong Research And Bolt-On Acquisitions
Post on 4/25/17
-
Better Buy: Amgen Inc. vs. Pfizer
Post on 4/25/17
-
Were Johnson & Johnson's Earnings Really That Bad?
Post on 4/25/17
-
Data Diagnostics Wins Gold at the 30th Annual Edison Awards
Post on 4/24/17
-
Novartis Expands Global Collaboration with Amgen
Post on 4/24/17
-
Diaceutics Signs Multi-Million-Dollar Partnership with BioReference Laboratories
Post on 4/24/17
-
ShopRite Joins Aetna’s Preferred Medicare Pharmacy Network
Post on 4/24/17
-
Merck Leads Rivals In Novel Drug Approvals
Post on 4/24/17
-
Johnson & Johnson: Modest Price Decline Presents Buying Opportunity
Post on 4/24/17
-
3 Things Johnson & Johnson Didn't Tell You in Its Q1 Earnings Update
Post on 4/24/17
-
Better Buy: AbbVie Inc. vs. Pfizer
Post on 4/24/17
-
Edison Awards Recognize Ortho Clinical Diagnostics for Outstanding Product Innovation
Post on 4/23/17
-
Pfizer: Relatively High Yield Healthcare Blue Chip
Post on 4/21/17
-
Better Buy: Verizon Communications Inc. vs. Johnson & Johnson
Post on 4/21/17
-
Onconova Therapeutics Announces Proposed Public Offering of Common Stock
Post on 4/21/17
-
Interpace Diagnostics Eliminates Long Term Secured Debt
Post on 4/20/17
-
Zillion Health and Vidyo Aim to Simplify Patient Engagement
Post on 4/20/17
-
FamilyWize Launches "Healthy You, Happy Orlando" Campaign
Post on 4/20/17
-
J&J Now Too Cheap To Its Peers To Ignore
Post on 4/20/17
-
Celgene: The Next Dominant Pharma Company - Celgene Corporation
Post on 4/20/17
-
5 Ways Johnson & Johnson Disappointed Us With Its Q1 Results
Post on 4/20/17
-
Johnson & Johnson: Was The Sell-Off Justified?
Post on 4/20/17
-
Edge Therapeutics Announces $18 Million Registered Direct Offering of Common Stock
Post on 4/19/17
-
Johnson & Johnson 2017 Q1 - Results - Earnings Call Slides
Post on 4/19/17
-
Is Johnson & Johnson At The Mercy Of The Business Cycle?
Post on 4/19/17
Philadelphia
